🧪In a trial in NEJM.org, scientists tested oral ensitrelvir for Covid postexposure prophylaxis vs. a placebo. Ensitrelvir administered to household contacts of a patient with Covid within 72 hours after symptom onset was effective in preventing Covid in contacts: https://ow.ly/2Tvx50Zb7So
